Education

AST podcasts and recordings

Podcasts

July 15, 2010

In this podcast, Dr. Angela Maldonado, Clinical Assistant Professor of Pharmacotherapy at Washington State University and Kidney Transplant Pharmacist at Providence Sacred Heart Medical Center and Children's Hospital, discusses the clinical services pharmacists provide in the outpatient transplant clinic. Dr. Maldonado describes the regulatory requirements, typical work flow, billing practices, and resource requirements to establish these services.

June 15, 2010

In this podcast, Dr. Patrick Niaudet, Head of Pediatric Nephrology Department, Professor of Pediatrics, Hopital Necker-Enfants Malades, a current editor for Pediatric Nephrology of "UpToDate", and a participating Editor of "Pediatric Nephrology", 2009, together with Dr. Amira Al-Uzri, Medical Director of the Pediatric Kidney Transplant Program, Associate Professor of Pediatrics, Oregon Health and Science University, discuss the topic of recurrent focal segmental glomerulosclerosis (FSGS) post kidney transplantation in children. Dr. Niaudet gives a thorough overview of the incidence and risk factors associated with recurrent FSGS post kidney transplantation, the genetic abnormalities present in a subset of patients, and potential new treatment options.

April 28, 2010

In this podcast, Dr. Jens Goebel, Medical Director of Kidney Transplantation at Cincinnati Children's and Associate Professor of Pediatrics, University of Cincinnati College of Medicine and Dr. Alicia Neu, Medical Director of Pediatric Dialysis and Kidney Transplantation at the Johns Hopkins Hospital, discuss the issue of chronic kidney disease (CKD) in non-kidney transplant patients with an emphasis on pediatric patients. Dr. Goebel describes the limitations of current methods of measuring glomerular function rate, the typical causes of CKD and potential mechanisms to slow progression of CKD in this population.

E.g., 10/23/2018
E.g., 10/23/2018
Join today to receive exclusive benefits.
View my membership
March 30, 2010

In this podcast, Dr. Gregory E. Malat, Transplant Pharmacist Hahnemann University Hospital and Assistant Professor Drexel University School of Medicine, and Dr. Eric M Tichy, Clinical Pharmacist from the Yale-New Haven Transplantation Center, discuss the unique issues regarding management of drug interactions between transplant immunosuppressants and highly active antiretroviral therapy (HAART). Dr. Malat describes the components of HAART regimens, reviews the impact HAART medications have on immunosuppressant drug levels, and provides recommendations for management of these issues in the clinical transplant setting.

March 22, 2010

In this podcast, Dr. Randall Sung, Associate Professor of Surgery and Surgical Director of the Kidney and Kidney Pancreas Transplant Program at the University of Michigan Medical School, discusses transplant outcomes of organs procured from donors after cardiac death. Dr. Sung discusses the details involved in the definition of donation after cardiac death, donor management and transplant outcomes as well as ethical issues associated with this modality. This podcast also provides practical, up-to-date information and advice to physicians who may have questions about the advantages and disadvantages of transplantation of organs from donors after cardiac death, and would like to counsel their transplant candidates about accepting organs procured from these donors.

December 31, 2009

Dr. George Mazariegos, Chief of Pediatric Transplantation and Liver Transplant Surgeon at Children's Hospital of Pittsburgh, and Professor of Surgery and Critical Care Medicine at University of Pittsburgh, discusses the challenges and current outcomes of neonatal liver transplantation. He reviews the diseases commonly leading to liver failure in the neonatal period and the unique considerations and challenges while awaiting organ availability. He also discusses the current medical and surgical outcomes after liver transplantation in neonates in 2010 including the outcomes with neonatal and infant donors, and other novel treatment alternatives in this challenging patient population.

December 18, 2009

Dr. Lisa McDevitt, Transplant Pharmacist at Tufts Medical Center and Assistant Professor at Tufts School of Medicine, discusses the unique issue regarding insurance coverage of immunosuppressive medications. She describes the differences in coverage offered by Medicare B and D as well as private insurance. In addition, the utilization of patient assistance programs and private grants are reviewed.

December 17, 2009

Dr. Patricia Harren, Clinical Director of the Pediatric Transplant Institute at Columbia University, discusses strategies to transition pediatric patients to the adult transplant team. Working with patients and their families in a team approach to prepare them with the necessary knowledge and skills to advocate for themselves and maintain continued health promoting behaviors allows for a smoother, successful transition.

December 17, 2009

Dr. Roslyn Mannon, Professor of Medicine and Surgery, and Director of Transplantation Research at the University of Alabama presents, a thorough discussion of the relevant issues in maligancy detection, diagnosis and management in patients with kidney transplants, the role of specific immunosuppression in patients with malignancies and gives guidelines for the waitlisting of patients with prior malignancies. The listener of this podcast will have up-to-date approaches to the pathophysiology of cancer as well as strategies for better detection and treatment in their kidney transplant patients.

December 17, 2009

In this podcast, Dr. Michelle Josephson, Professor of Medicine and Director of Transplantation Medicine at the University of Chicago, discusses Bone Disease in transplant recipients. She emphasizes the importance of understanding the pathophysiology of bone disease and discusses the current screening and treatment recommendations as well as the most current KDIGO recommendations. This podcast provides practical, up-to-date information and advice for physicians about how to diagnose and treat bone disease in the transplant patient population.

Pages

Educational Content Disclaimer: The content, information, opinions, and viewpoints contained in educational materials housed on and linked from the AST web site are those of the authors or contributors of such materials. While the AST and its committees take great care to screen the credentials of the contributors and make every attempt to review the contents, AST MAKES NO WARRANTY, EXPRESSED OR IMPLIED, as to the completeness or accuracy of the content contained in the educational materials or on this website. The reader of these materials uses these materials at his or her own risk, and AST shall not be responsible for any errors, omissions, or inaccuracies in these materials, whether arising through negligence, oversight, or otherwise. Reliance on any information appearing on this site is strictly at your own risk. Read the full disclaimer.